Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,921 to 1,940 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma. | Int J Biol Sci | 2022 | 35982900 | PubTator, text mining | PubMed |
| ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression. | Int J Biol Sci | 2022 | 35982895 | PubTator, text mining | PubMed |
| METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis. | Stem Cells Transl Med | 2022 | 35980318 | PubTator, text mining | PubMed |
| N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation. | Clin Transl Med | 2022 | 35979628 | PubTator, text mining | PubMed |
| Delicaflavone Represses Lung Cancer Growth by Activating Antitumor Immune Response through N6-Methyladenosine Transferases and Oxidative Stress. | Oxid Med Cell Longev | 2022 | 35979397 | PubTator, text mining | PubMed |
| m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma. | Comput Intell Neurosci | 2022 | 35978902 | PubTator, text mining | PubMed |
| ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators. | Front Oncol | 2022 | 35978821 | PubTator, text mining | PubMed |
| m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer. | Cell Death Dis | 2022 | 35977935 | PubTator, text mining | PubMed |
| Labeling and sequencing nucleic acid modifications using bio-orthogonal tools. | RSC Chem Biol | 2022 | 35975003 | PubTator, text mining | PubMed |
| YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. | J Exp Clin Cancer Res | 2022 | 35974388 | PubTator, text mining | PubMed |
| The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. | Mol Cancer | 2022 | 35974338 | PubTator, text mining | PubMed |
| m6A Modification-mediated GRAP Regulates Vascular Remodeling in Hypoxic Pulmonary Hypertension. | Am J Respir Cell Mol Biol | 2022 | 35972996 | PubTator, text mining | PubMed |
| m6A is required for resolving progenitor identity during planarian stem cell differentiation. | EMBO J | 2022 | 35971838 | PubTator, text mining | PubMed |
| m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma. | Front Immunol | 2022 | 35967408 | PubTator, text mining | PubMed |
| RNA N6 -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer. | Theranostics | 2022 | 35966596 | PubTator, text mining | PubMed |
| The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1. | Ann Transl Med | 2022 | 35965785 | PubTator, text mining | PubMed |
| Prognostic Evaluation for Oral Squamous Cell Carcinoma: A Novel Method Based on m6A Methylation Regulators. | Curr Med Sci | 2022 | 35963950 | PubTator, text mining | PubMed |
| FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway. | Cell Death Discov | 2022 | 35961973 | PubTator, text mining | PubMed |
| Alteration of RNA modification signature in human sperm correlates with sperm motility. | Mol Hum Reprod | 2022 | 35959987 | PubTator, text mining | PubMed |
| A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma. | Cells | 2022 | 35954243 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=97